Related Experiment Video
Updated: May 21, 2026
10:49
Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Rotavirus vaccination in developing countries
1Department of Gastrointestinal Sciences, Christian Medical College, Vellore, Tamil Nadu 632004, India.
Current Opinion in Virology
|June 16, 2012
Summary
Despite challenges, rotavirus vaccines can reduce disease burden in developing nations. Further research is needed for improved vaccine efficacy and strategies to combat rotavirus mortality.
Area of Science:
- Immunology
- Public Health
- Vaccinology
Background:
- Two oral rotavirus vaccines are available globally.
- Developing countries face challenges in adopting new vaccines.
- Rotavirus vaccines show lower efficacy in high-burden regions.
Purpose of the Study:
- To analyze factors influencing rotavirus vaccine introduction in developing countries.
- To assess the impact of existing rotavirus vaccines despite efficacy limitations.
- To explore strategies for future rotavirus vaccine development and implementation.
Main Methods:
- Review of existing literature on rotavirus vaccine efficacy and implementation.
- Analysis of financial and logistical barriers in resource-limited settings.
- Modeling disease burden reduction with current vaccine efficacy levels.
Main Results:
- Financial and logistical hurdles impede vaccine adoption.
- Lower vaccine efficacy observed in high-burden countries.
- Existing vaccines can significantly reduce rotavirus disease and mortality.
Conclusions:
- Rotavirus vaccines offer substantial benefits even with lower efficacy in developing countries.
- Addressing implementation challenges is crucial for maximizing vaccine impact.
- Development of improved vaccines and strategies is necessary to eliminate rotavirus disease burden.
Related Concept Videos
01:51Vaccinations
Overview
01:18Bacterial Gastroenteritis
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
01:21Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
01:23Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
01:25Cholera
Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.